Lilly Mark Selected Research

Naproxen (Naprosyn)

1/2004

Pharmacological characterisation of a rat model of incisional pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lilly Mark Research Topics

Disease

7	Infections 01/2023 - 12/2013
6	Pain (Aches) 09/2010 - 07/2003
5	Hyperalgesia 09/2010 - 07/2003
3	Inflammation (Inflammations) 01/2023 - 08/2004
3	Neuralgia (Stump Neuralgia) 09/2009 - 07/2003
2	Cystic Fibrosis (Mucoviscidosis) 01/2023 - 01/2021
2	Staphylococcal Infections 01/2016 - 12/2013
2	Catalepsy 12/2005 - 04/2005
2	Ataxia (Dyssynergia) 12/2005 - 04/2005
2	Chronic Pain 12/2005 - 04/2005
1	Peritonitis 01/2023
1	Bronchiectasis 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Hypersensitivity (Allergy) 09/2010
1	Ulcer 09/2010
1	Postoperative Pain 08/2004

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2021
3	TXA709IBA 01/2023 - 01/2016
3	Methicillin (Metin)FDA Link 10/2022 - 12/2013
3	Analgesics (Analgesic Drugs)IBA 12/2005 - 07/2003
2	ProdrugsIBA 01/2023 - 01/2016
2	LipoglycopeptidesIBA 11/2022 - 01/2021
2	Indomethacin (Indometacin)FDA LinkGeneric 09/2010 - 01/2004
2	CB2 Cannabinoid ReceptorIBA 12/2005 - 04/2005
2	1- (2,3- dichlorobenzoyl)- 5- methoxy- 2- methyl- (2- (mopholin- 4- yl)ethyl)- 1H- indoleIBA 12/2005 - 04/2005
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2005 - 04/2005
1	brensocatibIBA 01/2023
1	TXA707IBA 01/2023
1	Oxacillin (Prostaphlin)FDA LinkGeneric 10/2022
1	Vancomycin FDA LinkGeneric 01/2021
1	Cefdinir (Omnicef)FDA LinkGeneric 01/2016
1	N- (3- ((6- chlorothiazolo(5,4- b)pyridin- 2- yl)methoxy)- 2,6- difluorobenzoyl)- 1- methylpiperidine- 4- carboxamideIBA 12/2013
1	PC190723IBA 12/2013
1	TXY436IBA 12/2013
1	benzamideIBA 12/2013
1	CarrageenanIBA 09/2010
1	CP 154526IBA 09/2010
1	2- methyl- 4- (N- propyl- N- cycloproanemethylamino)- 5- chloro- 6- (2,4,6- trichloranilino)pyrimidineIBA 09/2010
1	SaporinsIBA 09/2010
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2010
1	compound 20IBA 09/2009
1	pyrimidineIBA 09/2006
1	Lamotrigine (Lamictal)FDA LinkGeneric 09/2006
1	Sodium Channel BlockersIBA 09/2006
1	Carbamazepine (Tegretol)FDA LinkGeneric 09/2006
1	CannabinoidsIBA 12/2005
1	Cannabinoid Receptor AgonistsIBA 04/2005
1	Naltrexone (ReVia)FDA LinkGeneric 08/2004
1	Opioid Analgesics (Opioids)IBA 08/2004
1	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2004
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2004
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2004
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2004
1	Celecoxib (Celebrex)FDA Link 01/2004
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2004
1	Morphine (MS Contin)FDA LinkGeneric 01/2004
1	EtoricoxibIBA 01/2004
1	CationsIBA 07/2003
1	Capsaicin (Zostrix)FDA Link 07/2003
1	capsazepineIBA 07/2003
1	TRPV Cation ChannelsIBA 07/2003
1	LigandsIBA 07/2003

Therapy/Procedure

2	Oral Administration 01/2016 - 09/2010
2	Therapeutics 01/2016 - 09/2006
2	Ligation 09/2009 - 09/2006
1	Analgesia 04/2005